Biocon Biologics' Management On Acquiring Biosimilars Business Of Viatris

Описание: Biologics, a subsidiary of Biocon, has announced that it will acquire Viatris’ biosimilars business in a $3.3 billion cash and stock deal. Listen in to the management's press address

#Biocon #Vitaris #Pharma

Follow us:
Website: https://www.moneycontrol.com/
Facebook:   / moneycontrol  
Twitter:   / moneycontrolcom  
Instagram:   / moneycontrolcom